Drug profile · INN
meningococcal group b vaccine (recombinant, adsorbed)
TRUMENBA
meningococcal group b vaccine (recombinant, adsorbed) (TRUMENBA) is a factor h binding protein vaccine antigen.
EMA: approved Antiinfectives for systemic use (J07) J07AH09
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — meningococcal group b vaccine (recombinant, adsorbed)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
meningococcal group b vaccine (recombinant, adsorbed) (TRUMENBA) is a factor h binding protein vaccine antigen.
Key facts
INN meningococcal group b vaccine (recombinant, adsorbed)
Brand TRUMENBA
Mechanism Factor H binding protein vaccine antigen
Target Factor H binding protein
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07AH09
Mechanism of action
Factor H binding protein vaccine antigen
Primary target: Factor H binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is meningococcal group b vaccine (recombinant, adsorbed)?
meningococcal group b vaccine (recombinant, adsorbed) (TRUMENBA) is a factor h binding protein vaccine antigen.
What is the brand name for meningococcal group b vaccine (recombinant, adsorbed)?
TRUMENBA is a marketed brand name for meningococcal group b vaccine (recombinant, adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.